The adaptor protein p66Shc inhibits mTOR-dependent anabolic metabolism

Science Signaling

Volumn 7, Issue 313, 2014, Pages

  Soliman, Mohamed A ^a,b,c   Abdel Rahman, Anas M ^a,h   Lamming, Dudley A ^d   Birsoy, Kivanç ^d   Pawling, Judy ^a   Frigolet, Maria E ^a,e   Lu, Huogen ^a,e   Fantus, I George ^a,e   Pasculescu, Adrian ^a   Zheng, Yong ^a   Sabatini, David M ^d,f,g   Dennis, James W ^a,b   Pawson, Tony ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CAIRO UNIVERSITY   (Egypt)

^d WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

^f MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^h YARMOUK UNIVERSITY   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; GLUCOSE; GLYCOLYSIS; HELA CELLS; HUMANS; MICE; MICE, KNOCKOUT; SHC SIGNALING ADAPTOR PROTEINS; SIGNAL TRANSDUCTION; SIROLIMUS; TOR SERINE-THREONINE KINASES;

EID: 84894284442     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004785     Document Type: Article

References (38)

1. J. D. Scott, T. Pawson, Cell signaling in space and time: Where proteins come together and when they're apart. Science 326, 1220-1224 (2009).
2. P. P. Hsu, S. A. Kang, J. Rameseder, Y. Zhang, K. A. Ottina, D. Lim, T. R. Peterson, Y. Choi, N. S. Gray, M. B. Yaffe, J. A. Marto, D. M. Sabatini, The mTOR-regulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 332, 1317-1322 (2011).
3. Y. Yu, S. O. Yoon, G. Poulogiannis, Q. Yang, X. M. Ma, J. Villén, N. Kubica, G. R. Hoffman, L. C. Cantley, S. P. Gygi, J. Blenis, Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 332, 1322-1326 (2011).
4. L. Wang, B. Balas, C. Y. Christ-Roberts, R. Y. Kim, F. J. Ramos, C. K. Kikani, C. Li, C. Deng, S. Reyna, N. Musi, L. Q. Dong, R. A. DeFronzo, F. Liu, Peripheral disruption of the Grb10 gene enhances insulin signaling and sensitivity in vivo. Mol. Cell. Biol. 27, 6497-6505 (2007).
5. F. M. Smith, L. J. Holt, A. S. Garfield, M. Charalambous, F. Koumanov, M. Perry, R. Bazzani, S. A. Sheardown, B. D. Hegarty, R. J. Lyons, G. J. Cooney, R. J. Daly, A. Ward, Mice with a disruption of the imprinted Grb10 gene exhibit altered body composition, glucose homeostasis, and insulin signaling during postnatal life. Mol. Cell. Biol. 27, 5871-5886 (2007).
6. M. G. Vander Heiden, L. C. Cantley, C. B. Thompson, Understanding the Warburg effect: The metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009).
7. D. Hanahan, R. A. Weinberg, Hallmarks of cancer: The next generation. Cell 144, 646-674 (2011).
8. G. Pelicci, L. Lanfrancone, F. Grignani, J. McGlade, F. Cavallo, G. Forni, I. Nicoletti, T. Pawson, P. G. Pelicci, A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70, 93-104 (1992).
9. shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway. EMBO J. 16, 706-716 (1997).
10. P. Pinton, A. Rimessi, S. Marchi, F. Orsini, E. Migliaccio, M. Giorgio, C. Contursi, S. Minucci, F. Mantovani, M. R. Wieckowski, S. G. Del, P. G. Pelicci, R. Rizzuto, Protein kinase C β and prolyl isomerase 1 regulate mitochondrial effects of the life-span determinant p66Shc. Science 315, 659-663 (2007).
11. shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402, 309-313 (1999).
12. L. E. Stevenson, A. R. Frackelton Jr., Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: Correlation with ErbB2 and p66 Shc expression. Breast Cancer Res. Treat. 49, 119-128 (1998).
13. shcA mediates obesity-induced insulin resistance. Proc. Natl. Acad. Sci. U.S.A. 107, 13420-13425 (2010).
14. A. A. Tomilov, J. J. Ramsey, K. Hagopian, M. Giorgio, K. M. Kim, A. Lam, E. Migliaccio, K. C. Lloyd, I. Berniakovich, T. A. Prolla, P. Pelicci, G. A. Cortopassi, The Shc locus regulates insulin signaling and adiposity in mammals. Aging Cell 10, 55-65 (2011).
15. Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 104, 5217-5222 (2007).
16. Shc knock out mice are short lived under natural condition. Aging Cell 11, 162-168 (2012).
17. M. Kisielow, S. Kleiner, M. Nagasawa, A. Faisal, Y. Nagamine, Isoform-specific knockdown and expression of adaptor protein ShcA using small interfering RNA. Biochem. J. 363, 1-5 (2002).
18. G. Hatzivassiliou, F. Zhao, D. E. Bauer, C. Andreadis, A. N. Shaw, D. Dhanak, S. R. Hingorani, D. A. Tuveson, C. B. Thompson, ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8, 311-321 (2005).
19. K. S. Lau, E. A. Partridge, A. Grigorian, C. I. Silvescu, V. N. Reinhold, M. Demetriou, J. W. Dennis, Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129, 123-134 (2007).
20. K. E. Wellen, C. Lu, A. Mancuso, J. M. Lemons, M. Ryczko, J. W. Dennis, J. D. Rabinowitz, H. A. Coller, C. B. Thompson, The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev. 24, 2784-2799 (2010).
21. Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122, 221-233 (2005).
22. K. H. Fisher-Wellman, P. D. Neufer, Linking mitochondrial bioenergetics to insulin resistance via redox biology. Trends Endocrinol. Metab. 23, 142-153 (2012).
23. N. Houstis, E. D. Rosen, E. S. Lander, Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944-948 (2006).
24. J. Munger, B. D. Bennett, A. Parikh, X. J. Feng, J. McArdle, H. A. Rabitz, T. Shenk, J. D. Rabinowitz, Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 26, 1179-1186 (2008).
25. K. Duvel, J. L. Yecies, S. Menon, P. Raman, A. I. Lipovsky, A. L. Souza, E. Triantafellow, Q. Ma, R. Gorski, S. Cleaver, M. G. Vander Heiden, J. P. MacKeigan, P. M. Finan, C. B. Clish, L. O. Murphy, B. D. Manning, Activation of a metabolic gene regulatory network downstream of mTOR complex 1. Mol. Cell 39, 171-183 (2010).
26. I. Ben-Sahra, J. J. Howell, J. M. Asara, B. D. Manning, Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1. Science 339, 1323-1328 (2013).
27. A. M. Robitaille, S. Christen, M. Shimobayashi, M. Cornu, L. L. Fava, S. Moes, C. Prescianotto-Baschong, U. Sauer, P. Jenoe, M. N. Hall, Quantitative phosphoproteomics reveal mTORC1 activates de novo pyrimidine synthesis. Science 339, 1320-1323 (2013).
28. R. Zoncu, A. Efeyan, D. M. Sabatini, mTOR: From growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35 (2011).
29. C. C. Thoreen, S. A. Kang, J. W. Chang, Q. Liu, J. Zhang, Y. Gao, L. J. Reichling, T. Sim, D. M. Sabatini, N. S. Gray, An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J. Biol. Chem. 284, 8023-8032 (2009).
30. G. Xi, X. Shen, D. R. Clemmons, p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment. Mol. Endocrinol. 22, 2162-2175 (2008).
31. S. Wullschleger, R. Loewith, M. N. Hall, TOR signaling in growth and metabolism. Cell 124, 471-484 (2006).
32. A. Hagiwara, M. Cornu, N. Cybulski, P. Polak, C. Betz, F. Trapani, L. Terracciano, M. H. Heim, M. A. Rüegg, M. N. Hall, Hepatic mTORC2 activates glycolysis and lipogenesis through Akt, glucokinase, and SREBP1c. Cell Metab. 15, 725-738 (2012).
33. D. W. Lamming, G. Demirkan, J. M. Boylan, M. M. Mihaylova, T. Peng, J. Ferreira, N. Neretti, A. Salomon, D. M. Sabatini, P. A. Gruppuso, Hepatic signaling by the mechanistic target of rapamycin complex 2 (mTORC2). FASEB J. 28, 300-315 (2014).
34. Y. Zheng, C. Zhang, D. R. Croucher, M. A. Soliman, N. St-Denis, A. Pasculescu, L. Taylor, S. A. Tate, W. R. Hardy, K. Colwill, A. Y. Dai, R. Bagshaw, J. W. Dennis, A. C. Gingras, R. J. Daly, T. Pawson, Temporal regulation of EGF signalling networks by the scaffold protein Shc1. Nature 499, 166-171 (2013).
35. G. Xi, X. Shen, Y. Radhakrishnan, L. Maile, D. Clemmons, Hyperglycemia-induced p66shc inhibits insulin-like growth factor I-dependent cell survival via impairment of Src kinase-mediated phosphoinositide-3 kinase/AKT activation in vascular smooth muscle cells. Endocrinology 151, 3611-3623 (2010).
36. A. M. Abdel Rahman, M. Ryczko, J. Pawling, J. W. Dennis, Probing the hexosamine biosynthetic pathway in human tumor cells by multitargeted tandem mass spectrometry. ACS Chem. Biol. 8, 2053-2062 (2013).
37. J. Xia, D. S. Wishart, Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat. Protoc. 6, 743-760 (2011).
38. K. Birsoy, T. Wang, R. Possemato, O. H. Yilmaz, C. E. Koch, W. W. Chen, A. W. Hutchins, Y. Gultekin, T. R. Peterson, J. E. Carette, T. R. Brummelkamp, C. B. Clish, D. M. Sabatini, MCT1-mediated transport of a toxic molecule is an effective strategy for targeting glycolytic tumors. Nat. Genet. 45, 104-108 (2013).